Status:
COMPLETED
Spartan Cube CYP2C19 Inter Laboratory Reproducibilty Study
Lead Sponsor:
Spartan Bioscience Inc.
Collaborating Sponsors:
Children's Hospital of Eastern Ontario
The Ottawa Hospital
Conditions:
Genotyping Techniques
Eligibility:
All Genders
Phase:
NA
Brief Summary
The study verifies that the Spartan Cube CYP2C19 System generates reproducible results under multi-variant conditions including test site (three different test sites), operators (two operators per sit...
Detailed Description
The reproducibility study (VNV-00227) is aimed at assessing the performance of the Spartan Cube CYP2C19 product under multi-variant conditions that include test site, operators, testing days, and reag...
Eligibility Criteria
Inclusion
- available for travel to three different sites, on 5 non-consecutive days.
Exclusion
- none
Key Trial Info
Start Date :
October 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04473573
Start Date
October 31 2019
End Date
March 17 2020
Last Update
July 16 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Eastern Ontario
Ottawa, Ontario, Canada, K1H 8L6
2
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada, K1H 8L6
3
The Univeristy of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y4W7